Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Hansbauer EM"'
Autor:
Heinzelmann K; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Fysikopoulos A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Jaquin TJ; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Peper-Gabriel JK; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Hansbauer EM; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Grüner S; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Prassler J; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Wurzenberger C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Kennedy JGC; Marsico Lung Institute/Cystic Fibrosis Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States., Snead JY; Marsico Lung Institute/Cystic Fibrosis Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States., Wrennall JA; Department of Cell Biology & Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States., Heinig K; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Wurzenberger C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Bel Aiba RS; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Tarran R; Division of Genetic, Environmental and Inhalational Disease, Department of Internal Medicine, Kansas University Medical Center, Kansas City, Kansas, United States., Livraghi-Butrico A; Marsico Lung Institute/Cystic Fibrosis Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States., Fitzgerald MF; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Anderson GP; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia., Rothe C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Matschiner G; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Olwill SA; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Hagner M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
Publikováno v:
American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2025 Jan 01; Vol. 328 (1), pp. L75-L92. Date of Electronic Publication: 2024 Nov 05.
Autor:
Piha-Paul S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Olwill SA; Pieris Pharmaceuticals, Freising, Germany., Hamilton E; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, United States., Tolcher A; South Texas Accelerated Research Therapeutics, San Antonio, TX, United States., Pohlmann P; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Liu SV; Georgetown University, Washington, DC, United States., Wurzenberger C; Pieris Pharmaceuticals, Hallbergmoos, Germany., Hasenkamp LC; Pieris Pharmaceuticals, Freising, Germany., Hansbauer EM; Pieris Pharmaceuticals, Hallbergmoos, Germany., Shroff R; University of Arizona, Tucson, AZ, United States., Hurvitz S; Fred Hutchinson Cancer Center, Seattle, WA, United States., Krishnamurthy A; Hillman Cancer Center, Pittsburgh, United States., Patnaik A; South Texas Accelerated Research Therapeutics, San Antonio, United States., Hahn N; Johns Hopkins School of Medicine, Baltimore, Maryland, United States., Kumar R; Pieris, Bavaria, Germany., Duerr M; Pieris Pharmaceuticals, Bavaria, Germany., Zettl M; CureVac (Germany), Tuebingen, Germany., Aviano K; Pieris Pharmaceuticals (United States), Massachusetts, United States., Matis L; Pieris Pharmaceuticals (United States), Massachusetts, United States., Bruns I; Bayer (United States), United States., Ku G; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.
Autor:
Peper-Gabriel JK; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Pavlidou M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Pattarini L; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Morales-Kastresana A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Jaquin TJ; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Gallou C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Hansbauer EM; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Richter M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Lelievre H; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France., Scholer-Dahirel A; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France., Bossenmaier B; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Sancerne C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Riviere M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Grandclaudon M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Zettl M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Bel Aiba RS; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Rothe C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Blanc V; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France., Olwill SA; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Aug 02; Vol. 28 (15), pp. 3387-3399.
Autor:
Siegemund M; Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany., Oak P; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Hansbauer EM; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Allersdorfer A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Utschick K; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Winter A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Grasmüller C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Galler G; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Mayer JP; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Weiche B; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Prassler J; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany., Kontermann RE; Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany.; Stuttgart Research Center Systems Biology, University of Stuttgart, Stuttgart, Germany., Rothe C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2021 Oct 25; Vol. 12, pp. 759337. Date of Electronic Publication: 2021 Oct 25 (Print Publication: 2021).
Autor:
Worbs S; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Kampa B; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Skiba M; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Hansbauer EM; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany.; Département Médicaments et Technologies pour la Santé, Université Paris Saclay, CEA, INRAE, SPI, 91191 Gif-sur-Yvette, France., Stern D; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Volland H; Département Médicaments et Technologies pour la Santé, Université Paris Saclay, CEA, INRAE, SPI, 91191 Gif-sur-Yvette, France., Becher F; Département Médicaments et Technologies pour la Santé, Université Paris Saclay, CEA, INRAE, SPI, 91191 Gif-sur-Yvette, France., Simon S; Département Médicaments et Technologies pour la Santé, Université Paris Saclay, CEA, INRAE, SPI, 91191 Gif-sur-Yvette, France., Dorner MB; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany., Dorner BG; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Seestr. 10, 13353 Berlin, Germany.
Publikováno v:
Toxins [Toxins (Basel)] 2021 Apr 18; Vol. 13 (4). Date of Electronic Publication: 2021 Apr 18.
Autor:
von Berg L; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Stern D; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Pauly D; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany.; Department of Ophthalmology, University Hospital Regensburg, Regensburg, 93053, Germany., Mahrhold S; Institut für Toxikologie, Medizinische Hochschule Hannover, 30625, Hannover, Germany., Weisemann J; Institut für Toxikologie, Medizinische Hochschule Hannover, 30625, Hannover, Germany., Jentsch L; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Hansbauer EM; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Müller C; Spiez Laboratory, Federal Office for Civil Protection, Spiez, 3700, Switzerland., Avondet MA; Spiez Laboratory, Federal Office for Civil Protection, Spiez, 3700, Switzerland., Rummel A; Institut für Toxikologie, Medizinische Hochschule Hannover, 30625, Hannover, Germany., Dorner MB; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany., Dorner BG; Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, 13353, Germany. DornerB@rki.de.
Publikováno v:
Scientific reports [Sci Rep] 2019 Apr 02; Vol. 9 (1), pp. 5531. Date of Electronic Publication: 2019 Apr 02.
Autor:
Hansbauer EM; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Worbs S; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute , Berlin, Germany., Volland H; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etudes et de Recherches en Immunoanalyse, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Simon S; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etudes et de Recherches en Immunoanalyse, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Junot C; Service de Pharmacologie et Immunoanalyse (SPI), CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Fenaille F; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France., Dorner BG; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute , Berlin, Germany., Becher F; Service de Pharmacologie et Immunoanalyse (SPI), Laboratoire d'Etude du Métabolisme des Médicaments, CEA, INRA, Université Paris Saclay , F-91191 Gif-sur-Yvette cedex, France.
Publikováno v:
Analytical chemistry [Anal Chem] 2017 Nov 07; Vol. 89 (21), pp. 11719-11727. Date of Electronic Publication: 2017 Oct 20.
Autor:
Hansbauer EM; Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute (RKI), Berlin, Germany. DornerB@rki.de., Skiba M, Endermann T, Weisemann J, Stern D, Dorner MB, Finkenwirth F, Wolf J, Luginbühl W, Messelhäußer U, Bellanger L, Woudstra C, Rummel A, Fach P, Dorner BG
Publikováno v:
The Analyst [Analyst] 2016 Sep 21; Vol. 141 (18), pp. 5281-97. Date of Electronic Publication: 2016 Jun 29.
Autor:
Woudstra C; Anses (French Agency for Food, Environmental and Occupational Health and Safety), Food Safety Laboratory, Maisons-Alfort, France., Le Maréchal C; Anses, Ploufragan-Plouzané Laboratory, Hygiene and Quality of Poultry and Pig Products Unit, Ploufragan, France Université Européenne de Bretagne, Rennes, France., Souillard R; Anses, Ploufragan-Plouzané Laboratory, Hygiene and Quality of Poultry and Pig Products Unit, Ploufragan, France Université Européenne de Bretagne, Rennes, France., Bayon-Auboyer MH; LABOCEA, Ploufragan, France., Anniballi F; Istituto Superiore di Sanità (ISS) Department of Veterinary Public Health and Food Safety, National Reference Centre for Botulism, Rome, Italy., Auricchio B; Istituto Superiore di Sanità (ISS) Department of Veterinary Public Health and Food Safety, National Reference Centre for Botulism, Rome, Italy., De Medici D; Istituto Superiore di Sanità (ISS) Department of Veterinary Public Health and Food Safety, National Reference Centre for Botulism, Rome, Italy., Bano L; Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe), Laboratorio di Treviso, Treviso, Italy., Koene M; Central Veterinary Institute (CVI) of Wageningen, UR, Lelystad, The Netherlands., Sansonetti MH; LNC, Veterinary Diagnostic Laboratory, Paita, New Caledonia., Desoutter D; LNC, Veterinary Diagnostic Laboratory, Paita, New Caledonia., Hansbauer EM; Robert Koch-Institut (RKI) Centre for Biological Threats and Special Pathogens, Biological Toxins, Consultant Laboratory for Clostridium botulinum, Berlin, Germany., Dorner MB; Robert Koch-Institut (RKI) Centre for Biological Threats and Special Pathogens, Biological Toxins, Consultant Laboratory for Clostridium botulinum, Berlin, Germany., Dorner BG; Robert Koch-Institut (RKI) Centre for Biological Threats and Special Pathogens, Biological Toxins, Consultant Laboratory for Clostridium botulinum, Berlin, Germany., Fach P; Anses (French Agency for Food, Environmental and Occupational Health and Safety), Food Safety Laboratory, Maisons-Alfort, France patrick.fach@anses.fr.
Publikováno v:
Applied and environmental microbiology [Appl Environ Microbiol] 2015 Apr; Vol. 81 (7), pp. 2495-505. Date of Electronic Publication: 2015 Jan 30.
Autor:
Goerttler, Tsepo, Dorner, Martin B., van der Linden, Christina, Kienitz, Ricardo, Petrik, Stephan, Blechinger, Stephan, Spickschen, Jonah, Betz, Iris R., Hinrichs, Carl, Steindl, David, Weber, Frederike, Musacchio, Thomas, Wunderlich, Gilbert, Rueger, Maria Adele, Barbe, Michael T., Dafsari, Haidar, Demir, Seda, Lapa, Sriramya, Zeiner, Pia S., Strzelczyk, Adam
Publikováno v:
Neurological Research & Practice; 10/29/2024, Vol. 6 Issue 1, p1-6, 6p